Wells Fargo notes that the Centers for Medicare & Medicaid Services finalized a -1.3% rate update for Home Health in 2026. While some improvement was expected, this is much better, the firm argues. Final rate a 5.1% improvement from proposed, largely driven by lower permanent and temporary adjustment headwinds. Wells views this as positive for Pennant Group (PNTG) and BrightSpring Health (BTSG).
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- BrightSpring Health initiated with an Outperform at BMO Capital
- BrightSpring Health Services, Inc.: Strong Growth Potential and Buy Rating Affirmed by BMO Capital
- BrightSpring Health price target raised to $39 from $33 at Wells Fargo
- BrightSpring Health price target raised to $40 from $32 at Morgan Stanley
- BrightSpring Health Services Shines in Q3 Earnings Call